167
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Placental leptin mRNA expression and serum leptin levels in pre-eclampsia associated with HIV infection

, , , , , , & show all
Pages 48-52 | Received 28 Jul 2015, Accepted 23 Jun 2016, Published online: 03 Oct 2016

References

  • Baker P, Kingdom JE. 2004. Pre-eclampsia – current perspectives on management. Parthenon: UK.
  • Brown MA, Lindheimer MD, de Swiet M, Van Asshe A, Moutquin J. 2001. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the international society for the study of hypertention in pregnancy (ISSHP). Hypertension in Pregnancy 20:ix–xiv.
  • Cnossen JS, Van Der Post JA, Mol BW, Khan KS, Meads CA, Ter Riet G. 2006. Prediction of pre-eclampsia: a protocol for systematic reviews of test accuracy. BioMed Central Pregnancy and Childbirth 6:29.
  • Coll O, Suy A, Martinez E, Lonca M, Lazzari E, Pisa S, et al. 2004. Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. Conference on Retroviruses and Opportunistic Infections; San Francisco, California, USA. abstract no. 921.
  • Conde-Agudelo A, Villar J, Lindheimer M. 2008. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. American Journal of Obstetrics & Gynecology 198:7–22.
  • De Groot MR, Corporaal LJ, Cronje HS, Joubert G. 2003. HIV infection in critically ill obstetrical patients. International Journal of Gynecology and Obstetrics 81:9–16.
  • Department of Health. 2012. Saving Mother's Report; Pretoria, South Africa.
  • Fiala M, Murphy T, Macdougall J, Yang W, Luque A, Iruela-Arispe L, et al. 2004. HAART drugs induce mitochondrial damage and intercellular gaps and gp120 causes apoptosis. Cardiovascular Toxicology 4:327–337.
  • Flint OP, Noor MA, Hruz PW, Hylemon PB, Yarasheski K, Kotler DP, et al. 2009. The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications. Toxicologic Pathology 37:65–77.
  • Giralt M, Domingo P, Guallar JP, Rodriguez De La Concepcion ML, Alegre M, Domingo JC, Villarroya F. 2006. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy. Antiviral Therapy 11:729–740.
  • Grinspoon S, Carr A. 2005. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. New England Journal of Medicine 352:48–62.
  • Grinspoon S, Mulligan K. 2003. Weight loss and wasting in patients infected with human immunodeficiency virus. Clinical Infectious Diseases 36:S69–S78.
  • Haffejee F, Naicker T, Singh M, Moodley J. 2013. Placental leptin in HIV-associated preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology 171:271–276.
  • Huppertz B. 2008. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 51:970–975.
  • Kafulafula GE, Moodley J, Ojwang PJ, Kagoro H. 2002. Leptin and pre-eclampsia in black African parturients. BJOG: An International Journal of Obstetrics and Gynaecology 109:1256–1261.
  • Kline ER, Sutliff RL. 2008. The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction. Journal of Investigative Medicine 56:752–769.
  • La Cava A, Matarese G. 2004. The weight of leptin in immunity. Nature Reviews Immunology 4:371–379.
  • Laivuori H, Gallaher MJ, Collura L, Crombleholme WR, Markovic N, Rajakumar A, et al. 2006. Relationships between maternal plasma leptin, placental leptin mRNA and protein in normal pregnancy, pre-eclampsia and intrauterine growth restriction without pre-eclampsia. Molecular Human Reproduction 12:551–556.
  • Laivuori H, Kaaja R, Koistinen H, Karonen SL, Andersson S, Koivisto V, Ylikorkala O. 2000. Leptin during and after preeclamptic or normal pregnancy: its relation to serum insulin and insulin sensitivity. Metabolism 49:259–263.
  • Le Bouteiller P, Tabiasco J. 2006. Killers become builders during pregnancy. Nature Medicine 12:991–992.
  • Lea RG, Howe D, Hannah LT, Bonneau O, Hunter L, Hoggard N. 2000. Placental leptin in normal, diabetic, and fetal growth-retarded pregnancies. Molecular Human Reproduction 6:763–769.
  • Lorquet S, Pequeux C, Munaut C, Foidart JM. 2010. Aetiology and physiopathology of preeclampsia and related forms. Acta Clinica Belgica 65:237–241.
  • Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, et al. 1995. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine 1:1155–1161.
  • Mallewa JE, Wilkins E, Vilar J, Mallewa M, Doran D, Back D, Pirmohamed M. 2008. HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options. Antimicrobial Chemotherapy 62:648–660.
  • Margetic S, Gazzola C, Pegg GG, Hill RA. 2002. Leptin: a review of its peripheral actions and interactions. International Journal of Obesity and Related Metabolic Disorders 26:1407–1433.
  • Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, et al. 1997. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nature Medicine 3:1029–1033.
  • Mcintyre J. 2003. Mothers infected with HIV. British Medical Bulletin 67:127–135.
  • Mise H, Yura S, Itoh H, Nuamah MA, Takemura M, Sagawa N, Fujii S. 2007. The relationship between maternal plasma leptin levels and fetal growth restriction. Endocrine Journal 54:945–951.
  • Naicker T, Khedun SM, Moodley J. 2002. Transforming growth factor beta(1) levels in platelet depleted plasma in African women with pre-eclampsia. Journal of Obstetrics and Gynaecology 22:279–282.
  • Otero M, Lago R, Lago F, Casanueva FF, Dieguez C, Gomez-Reino JJ, Gualillo O. 2005. Leptin, from fat to inflammation: old questions and new insights. FEBS Letters 579:295–301.
  • Redman CW, Sargent IL. 2003. Pre-eclampsia, the placenta and the maternal systemic inflammatory response - a review. Placenta 24:S21–S27.
  • Redman CW, Sargent IL. 2009. Placental stress and pre-eclampsia: a revised view. Placenta 23:S38–S42.
  • Reitman ML, Arioglu E, Gavrilova O, Taylor SI. 2000. Lipoatrophy revisited. Trends in Endocrinology & Metabolism 11:410–416.
  • Singh R, Gaiha G, Werner L, Mckim K, Mlisana K, Luban J, et al. 2011. Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection. Journal of Virology 85:208–216.
  • Souren NY, Paulussen AD, Steyls A, Loos RJ, Stassen AP, Gielen M, et al. 2008. Common SNPs in LEP and LEPR associated with birth weight and type 2 diabetes-related metabolic risk factors in twins. International Journal of Obesity 32:1–7.
  • Steinberger J, Jacobs DR, Raatz S, Moran A, Hong CP, Sinaiko AR. 2005. Comparison of body fatness measurements by BMI and skinfolds versus dual energy X-ray absorptiometry and their relation to cardiovascular risk factors in adolescents. International Journal of Obesity (London) 29:1346–1352.
  • Suy A, Martinez E, Coll O, Lonca M, Palacio M, De Lazzari E, et al. 2006. Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS 20:59–66.
  • Wang J, Wang H, Luo W, Guo C, Wang J, Chen YE, et al. 2013. Leptin-induced endothelial dysfunction is mediated by sympathetic nervous system activity. Journal American Heart Association 2:e000299.
  • Wimalasundera RC, Larbalestier N, Smith JH, De Ruiter A, Mcg Thom SA, Hughes AD, et al. 2002. Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet 360:1152–1154.
  • Wunder D, Bersinger NA, Fux C, Weber R, Bernasconi E, Cavassini M, et al. 2005. Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy. AIDS 19:1837–1842.
  • Zhang F, Basinski MB, Beals JM, Briggs SL, Churgay LM, Clawson DK, et al. 1997. Crystal structure of the obese protein leptin-E100. Nature 387:206–209.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.